Fifteen Years of Cardiac Safety: History, State-of-the- Science Research, and Glimpses into the Future

Apr 11, 2013

The field of cardiac safety employs clinical, statistical, and regulatory sciences during the preclinical and clinical development program of a noncardiac drug to prospectively exclude unacceptable cardiac risk before the drug receives marketing approval. Since December 2012 can be said to mark the 15th Anniversary of the regulatory science of cardiac safety J. Rick TurnerQuintiles. Snehal Kothari, Christopher H. Cabell, Dilip Karnad. & Dhiraj Narula of Cardiac Safety Services at Quintiles, reflects upon the field’s history, review current state-of- the-science research, and consider directions in which the field may move in the five or so years. [prettyfilelink src=”http://ipimediaworld.com/wp-content/uploads/2013/04/Fifteen-Years-of-Cardiac-Safety-History-State-of-the-Science-Research-and-Glimpses-into-the-Future.pdf” type=”pdf”]Fifteen Years ...

Read More

Counterfeit medicines: a real danger to patients

Apr 11, 2013

Counterfeit medicine has been a subject of much concern for as long as the health and pharmaceutical sector has been established. Counterfeit drugs are a social problem. Javier Sanz at Nekicesa looks into the illegal activity in counterfeit medicine and why everyone in the supply chain, including the consumer and patients has a key role in this fight against fake drugs. [prettyfilelink src=”http://ipimediaworld.com/wp-content/uploads/2013/04/Counterfeit-Medicines-A-Real-Danger-to-Patienst.pdf” type=”pdf”]Counterfeit Medicines A Real Danger to Patienst[/prettyfilelink] ...

Read More

Collaborative Development: Finding Solutions for the Packaging Challenges of Modern Injectable Biologics

Apr 11, 2013

For the past 20 years, biotechnology medicines have aided those suffering from chronic conditions, including cancer, diabetes, and auto-immune diseases such as multiple sclerosis and rheumatoid arthritis. Graham Reynolds at West Pharmaceutical Services looks at the success of biologics, which offer patients better long- term outcomes and fewer side-effects than traditional, chemical- based therapies, and how this has led to a rise in biological drugs over the past several years. [prettyfilelink src=”http://ipimediaworld.com/wp-content/uploads/2013/04/Collaborative-Development-Finding-Solutions-for-the-Packaging-Challenges-of-Modern-Injectable-Biologics.pdf” type=”pdf”]Collaborative Development Finding Solutions for the Packaging Challenges of Modern Injectable Biologics[/prettyfilelink] ...

Read More

Pure and Safe

Apr 11, 2013

Sterile services departments must ensure the consistent supply of sterilised tools and equipment throughout the hospital, and failure or delay can be distressing or dangerous. The critical nature of the work carried out by SSDs means that it is essential that standards are adhered to and, just as importantly, that the equipment used is correctly designed, manufactured and validated. Mark Bosley at Purite explains why purified water is a vital component in the decontamination process. [prettyfilelink src=”http://ipimediaworld.com/wp-content/uploads/2013/04/Pure-and-Safe.pdf” type=”pdf”]Pure and Safe[/prettyfilelink] ...

Read More

Hands-on Lean Plus

Apr 11, 2013

Socio-economic pressure as well as increasingly strong competition have clearly made the entire healthcare industry focus a lot of attention on reducing costs. Not so long ago Costs per kilogram, OEE, and number of Stock Turns were ‘alien’ indicators to the pharmaceutical industry, but now they are considered virtually ‘holy’ figures. In this article, Wim Spook at Matcon Ltd delivers some hands-on examples that will help improve your solid dosage facility, all approached from a powder-handling point of view. [prettyfilelink src=”http://ipimediaworld.com/wp-content/uploads/2013/04/Hands-on-Lean-Plus.pdf” type=”pdf”]Hands-on Lean Plus[/prettyfilelink] ...

Read More